国家健康创新能力评价及国际比较研究

Research on Evaluation and Comparison of National Health Innovation Ability

从创新要素、创新开发、创新扩散、医疗环境和社会环境等方面构建了国家健康创新能力的评价指标体系,以2017年统计数据为样本,应用主成分分析法对38个国家的健康创新能力进行了评价,并从国际比较视角对健康创新能力的格局进行了聚类分析。结果显示:①中国健康创新能力整体处于前列,但与部分发达国家仍然存在一定差距;②创新要素、创新扩散、医疗环境成为影响中国健康创新能力的重要因素;③健康创新能力的持续改善有赖于国家经济总体水平和人均公共卫生投入,国家健康创新能力排名较高的国家通常经济发展水平也较高。

This paper constructs an evaluation index framework for national health innovation ability from the perspectives of innovation elements,innovation development,innovation diffusion,health environment and social environment.This paper applies the principal components analysis(PCA)method to evaluate the national health innovation abilities of 38 countries based on the 2017 statistical data.The results show that:①national health innovation ability of China ranks at the forefront as a whole,however,there is still a gap between China and some developed countries;②the factors of innovation elements,innovation diffusion,and health environment have become the main impediment affecting China's health innovation ability;③the key to the continuous improvement of national health innovation ability lies in the country's economic level and public health investment.Basically,countries with higher national health innovation ability have higher economy level.